Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 2528 | 3810 | 37.2 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CARCINOGENESIS | journal | 167469 | 13% | 4% | 492 |
| 2 | CELL TRANSFORMATION ASSAY | authKW | 164127 | 1% | 79% | 26 |
| 3 | BHAS 42 CELLS | authKW | 82412 | 0% | 86% | 12 |
| 4 | ANTITUMOR IMMUN | address | 40063 | 0% | 100% | 5 |
| 5 | BALB C 3T3 CELL LINE | authKW | 40063 | 0% | 100% | 5 |
| 6 | HYDROPEROXIDE PRODUCTION | authKW | 32051 | 0% | 100% | 4 |
| 7 | TUMOR PROMOTION | authKW | 30941 | 1% | 10% | 39 |
| 8 | ONCOLOGY | WoSSC | 26394 | 43% | 0% | 1651 |
| 9 | PROGRESSIVE STATE SELECTION | authKW | 25639 | 0% | 80% | 4 |
| 10 | PROTECT MAN ECOSYST | address | 25639 | 0% | 80% | 4 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 26394 | 43% | 0% | 1651 |
| 2 | Toxicology | 7634 | 14% | 0% | 531 |
| 3 | CYTOLOGY & HISTOLOGY | 3354 | 1% | 1% | 57 |
| 4 | Cell Biology | 1577 | 12% | 0% | 465 |
| 5 | Dermatology | 1447 | 5% | 0% | 197 |
| 6 | Pathology | 1113 | 5% | 0% | 209 |
| 7 | Respiratory System | 427 | 3% | 0% | 128 |
| 8 | Genetics & Heredity | 273 | 5% | 0% | 190 |
| 9 | Biochemistry & Molecular Biology | 260 | 12% | 0% | 444 |
| 10 | Biology | 246 | 3% | 0% | 114 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANTITUMOR IMMUN | 40063 | 0% | 100% | 5 |
| 2 | PROTECT MAN ECOSYST | 25639 | 0% | 80% | 4 |
| 3 | ABT VIROL | 18627 | 1% | 8% | 30 |
| 4 | NN BLOKCHIN CANC | 18027 | 0% | 75% | 3 |
| 5 | CELL CARCINOGENESIS | 16025 | 0% | 100% | 2 |
| 6 | CELLULAR CARCINOGENESIS TUMOR PROMOT BLDG 37 | 16025 | 0% | 100% | 2 |
| 7 | NUTR FOOD SCI ROOM 56213 | 16025 | 0% | 100% | 2 |
| 8 | PROGRAM MECH TUMORIGENESIS | 16025 | 0% | 100% | 2 |
| 9 | URBAN AREAS | 16025 | 0% | 100% | 2 |
| 10 | HISTOL PATHOL ANAT SECT | 12815 | 0% | 40% | 4 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CARCINOGENESIS | 167469 | 13% | 4% | 492 |
| 2 | CANCER RESEARCH | 20887 | 8% | 1% | 321 |
| 3 | MOLECULAR CARCINOGENESIS | 17038 | 2% | 3% | 77 |
| 4 | IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION | 9766 | 1% | 5% | 27 |
| 5 | VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY | 9205 | 1% | 3% | 38 |
| 6 | CANCER LETTERS | 8607 | 3% | 1% | 115 |
| 7 | CELL BIOLOGY AND TOXICOLOGY | 8329 | 1% | 3% | 35 |
| 8 | IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY | 6905 | 1% | 3% | 29 |
| 9 | TOXICOLOGY IN VITRO | 5719 | 1% | 1% | 56 |
| 10 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 4864 | 2% | 1% | 81 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | DIGIOVANNI, J , (1992) MULTISTAGE CARCINOGENESIS IN MOUSE SKIN.PHARMACOLOGY & THERAPEUTICS. VOL. 54. ISSUE 1. P. 63-128 | 159 | 40% | 460 |
| 2 | SAKAI, A , IWASE, Y , NAKAMURA, Y , SASAKI, K , TANAKA, N , UMEDA, M , (2002) USE OF A CELL TRANSFORMATION ASSAY WITH ESTABLISHED CELL LINES, AND A METABOLIC COOPERATION ASSAY WITH V79 CELLS FOR THE DETECTION OF TUMOUR PROMOTERS: A REVIEW.ATLA-ALTERNATIVES TO LABORATORY ANIMALS. VOL. 30. ISSUE 1. P. 33 -59 | 83 | 64% | 17 |
| 3 | BUDUNOVA, IV , WILLIAMS, GM , (1994) CELL-CULTURE ASSAYS FOR CHEMICALS WITH TUMOR-PROMOTING OR TUMOR-INHIBITING ACTIVITY-BASED ON THE MODULATION OF INTERCELLULAR COMMUNICATION.CELL BIOLOGY AND TOXICOLOGY. VOL. 10. ISSUE 2. P. 71-116 | 103 | 56% | 89 |
| 4 | ABEL, EL , ANGEL, JM , KIGUCHI, K , DIGIOVANNI, J , (2009) MULTI-STAGE CHEMICAL CARCINOGENESIS IN MOUSE SKIN: FUNDAMENTALS AND APPLICATIONS.NATURE PROTOCOLS. VOL. 4. ISSUE 9. P. 1350 -1362 | 52 | 46% | 158 |
| 5 | YUSPA, SH , (1994) THE PATHOGENESIS OF SQUAMOUS-CELL CANCER - LESSONS LEARNED FROM STUDIES OF SKIN CARCINOGENESIS - 33RD GHA-CLOWES-MEMORIAL-AWARD LECTURE.CANCER RESEARCH. VOL. 54. ISSUE 5. P. 1178-1189 | 74 | 49% | 237 |
| 6 | CORVI, R , AARDEMA, MJ , GRIBALDO, L , HAYASHI, M , HOFFMANN, S , SCHECHTMAN, L , VANPARYS, P , (2012) ECVAM PREVALIDATION STUDY ON IN VITRO CELL TRANSFORMATION ASSAYS: GENERAL OUTLINE AND CONCLUSIONS OF THE STUDY.MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS. VOL. 744. ISSUE 1. P. 12 -19 | 26 | 84% | 24 |
| 7 | KLAUNIG, JE , RUCH, RJ , (1990) ROLE OF INHIBITION OF INTERCELLULAR COMMUNICATION IN CARCINOGENESIS.LABORATORY INVESTIGATION. VOL. 62. ISSUE 2. P. 135-146 | 74 | 52% | 141 |
| 8 | SCHECHTMAN, LM , (2012) RODENT CELL TRANSFORMATION ASSAYS-A BRIEF HISTORICAL PERSPECTIVE.MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS. VOL. 744. ISSUE 1. P. 3 -7 | 22 | 88% | 8 |
| 9 | BAUER, G , (2014) TARGETING EXTRACELLULAR ROS SIGNALING OF TUMOR CELLS.ANTICANCER RESEARCH. VOL. 34. ISSUE 4. P. 1467-1482 | 37 | 42% | 24 |
| 10 | OESCH, F , FABIAN, E , GUTH, K , LANDSIEDEL, R , (2014) XENOBIOTIC-METABOLIZING ENZYMES IN THE SKIN OF RAT, MOUSE, PIG, GUINEA PIG, MAN, AND IN HUMAN SKIN MODELS.ARCHIVES OF TOXICOLOGY. VOL. 88. ISSUE 12. P. 2135 -2190 | 62 | 26% | 15 |
Classes with closest relation at Level 2 |